相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort
Jose Carlos Jaime-Perez et al.
CLINICAL RHEUMATOLOGY (2022)
Individualised dosing of anti-thymocyte globulin in paediatric unrelated allogeneic haematopoietic stem-cell transplantation (PARACHUTE): a single-arm, phase 2 clinical trial
Rick Admiraal et al.
Lancet Haematology (2022)
Antithymocyte globulin exposure in CD34 + T-cell-depleted allogeneic hematopoietic cell transplantation
Madhavi Lakkaraja et al.
BLOOD ADVANCES (2022)
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party
Joerg Henes et al.
HAEMATOLOGICA (2021)
Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
Shun-ichi Kimura et al.
TRANSPLANT INFECTIOUS DISEASE (2021)
Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience
Alvaro Henrique-Neto et al.
ADVANCES IN RHEUMATOLOGY (2021)
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol
Julia Spierings et al.
BMJ OPEN (2021)
Autologous stem-cell transplantation in systemic sclerosis-associated interstitial lung disease: early action in selected patients rather than escalation therapy for all
J. Spierings et al.
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE (2021)
Reconstitution of T Cell Subsets Following Allogeneic Hematopoietic Cell Transplantation
Linde Dekker et al.
CANCERS (2020)
CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan
Masahiro Ayano et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis
Rick Admiraal et al.
LANCET HAEMATOLOGY (2017)
Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation
L. Binkert et al.
BONE MARROW TRANSPLANTATION (2015)
Population Pharmacokinetic Modeling of Thymoglobulin (R) in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing
Rick Admiraal et al.
CLINICAL PHARMACOKINETICS (2015)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt et al.
LANCET (2011)
Incidence and prevalence of systemic sclerosis: A systematic literature review
Helene Chifflot et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2008)
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
M. Mohty
LEUKEMIA (2007)
Rabbit antithymocyte globulin inhibits monocyte-derived dendritic cells maturation in vitro and polarizes monocyte-derived dendritic cells towards tolerogenic dendritic cells expressing indoleamine 2,3-dioxygenase
Stephanie Gillet-Hladky et al.
TRANSPLANTATION (2006)
Functional antibodies to leukocyte adhesion molecules in antithymocyte globulins.
MC Michallet et al.
TRANSPLANTATION (2003)
Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells
P Monti et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2003)